---
schema_version: "secwatch.filing_event.v1"
accession: "0001339970-26-000068"
form_type: "8-K"
ticker: "ATYR"
cik: "0001339970"
company_name: "aTYR PHARMA INC"
filed_at: "2026-10-16T20:02:31+00:00"
generated_at: "2026-10-16T20:03:03.428607+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# aTyr Pharma holders approve reverse stock split of 1-for-10 to 1-for-50 at Board's discretion

## Summary
- Proposal 1 approved: alternate charter amendments let the Board effect a reverse split at any ratio between 1-for-10 and 1-for-50, inclusive, in its sole discretion.
- Vote tally: 52,451,734 for, 5,234,645 against, 228,991 abstained, no broker non-votes.
- 57,915,370 shares, or about 59.04% of shares outstanding, were represented at the October 16, 2026 Special Meeting.
- Record date was September 4, 2026, with 98,087,425 shares of common stock outstanding and entitled to vote.
- Filing does not state a split ratio, timing, or effective date; those remain subject to future Board determination.

## SEC filing metadata
- accession: 0001339970-26-000068
- form_type: 8-K
- ticker: ATYR
- cik: 0001339970
- company_name: aTYR PHARMA INC
- filed_at: 2026-10-16T20:02:31+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339970/000133997026000068/0001339970-26-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339970/000133997026000068/atyr-20261016.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001339970-26-000068
- JSON: https://secwatch.observer/filing/0001339970-26-000068.json
- Plain text: https://secwatch.observer/filing/0001339970-26-000068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.